StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The significant stock decline of 43% indicates severe market loss and lack of confidence.
What happened, with direct paths to the underlying reporting
Shattuck Labs Inc. stock fell 43% after scrapping main product candidate. Company to cut 40% of its staff as part of restructuring. Termination of license agreement with Ono Pharmaceutical causes further investor concern. Stock is down 72% year-to-date versus biotech ETFs gaining 6-8%. Previous high price of $60.52 contrasts sharply with current low of $1.37.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.